BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27531964)

  • 1. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
    Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
    Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
    Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease.
    Parameswaran R; de Jong MC; Kit JLW; Sek K; Nam TQ; Thang TV; Khue NT; Aye TT; Tun PM; Cole T; Miller JA; Villa M; Khiewvan B; Sirinvaravong S; Sin YL; Muhammad R; Jap TS; Agrawal A; Rajput R; Fernando R; Sumanatilleke M; Suastika K; Shong YK; Lang B; Bartalena L; Yang SP;
    Endocrine; 2023 Jan; 79(1):135-142. PubMed ID: 36129592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, management and outcomes of Graves' disease-real life data.
    Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
    Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of Graves' disease in New Zealand 2014.
    Cox SC; Tamatea JA; Conaglen JV; Elston MS
    N Z Med J; 2016 Jun; 129(1436):10-24. PubMed ID: 27355225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
    Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A
    Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of Graves' disease in New Zealand: results of a national survey.
    Ford HC; Delahunt JW; Feek CM
    N Z Med J; 1991 Jun; 104(914):251-2. PubMed ID: 2057150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 2011 survey of clinical practice patterns in the management of Graves' disease.
    Burch HB; Burman KD; Cooper DS
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
    Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
    Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2013 European survey of clinical practice patterns in the management of Graves' disease.
    Bartalena L; Burch HB; Burman KD; Kahaly GJ
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):115-20. PubMed ID: 25581877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Graves' disease in Australia.
    Walsh JP
    Aust N Z J Med; 2000 Oct; 30(5):559-66. PubMed ID: 11108065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
    Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' perceptions and views of surgery and radioiodine ablation in the definitive management of Graves' disease.
    Hookham J; Truran P; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 May; 93(1099):266-270. PubMed ID: 27651496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of adult Graves' disease.
    Corvilain B; Hamy A; Brunaud L; Borson-Chazot F; Orgiazzi J; Bensalem Hachmi L; Semrouni M; Rodien P; Lussey-Lepoutre C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):618-635. PubMed ID: 30193753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of Graves' disease by Indian thyroidologists.
    Mithal A; Shah A; Kumar S
    Natl Med J India; 1993; 6(4):163-6. PubMed ID: 7691310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
    Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
    Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.